Richard Newitter
Stock Analyst at Truist Securities
(3.97)
# 573
Out of 5,149 analysts
455
Total ratings
50.55%
Success rate
10.89%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Buy | $47 → $30 | $25.90 | +15.83% | 17 | Mar 2, 2026 | |
| KIDS OrthoPediatrics | Maintains: Hold | $19 → $20 | $19.22 | +4.06% | 11 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Maintains: Buy | $82 → $89 | $76.30 | +16.64% | 23 | Mar 2, 2026 | |
| SIBN SI-BONE | Reiterates: Buy | $23 → $24 | $15.70 | +52.87% | 2 | Feb 24, 2026 | |
| IRTC iRhythm Holdings | Reiterates: Buy | $215 → $200 | $128.46 | +55.69% | 20 | Feb 23, 2026 | |
| TNDM Tandem Diabetes Care | Reiterates: Hold | $24 → $27 | $25.23 | +7.02% | 5 | Feb 23, 2026 | |
| ITGR Integer Holdings | Maintains: Buy | $95 → $97 | $86.34 | +12.35% | 13 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $390 → $360 | $245.45 | +46.67% | 5 | Feb 19, 2026 | |
| DXCM DexCom | Reiterates: Buy | $82 → $80 | $73.78 | +8.43% | 4 | Feb 17, 2026 | |
| INSP Inspire Medical Systems | Maintains: Hold | $96 → $70 | $64.81 | +8.01% | 31 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $92 → $89 | $87.18 | +2.09% | 23 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $95 | $76.22 | +24.64% | 21 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $25 | $12.52 | +99.68% | 6 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $342.30 | +9.26% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $35.36 | +27.26% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $1.66 | +80.72% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $400 → $392 | $387.02 | +1.29% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $110 → $107 | $98.10 | +9.07% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $496.25 | +30.98% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $121.12 | +19.72% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $93.80 | +11.94% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $13.37 | +49.59% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $10.43 | +43.82% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $122.93 | +11.45% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $99.49 | +13.58% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $7.61 | +162.81% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $84.68 | -3.16% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $176.54 | +41.61% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.00 | +766.67% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $189.02 | +307.36% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $75.45 | +12.66% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $11.99 | +66.81% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $30.65 | -11.91% | 5 | Feb 23, 2021 |
PROCEPT BioRobotics
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $25.90
Upside: +15.83%
OrthoPediatrics
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $19.22
Upside: +4.06%
Lantheus Holdings
Mar 2, 2026
Maintains: Buy
Price Target: $82 → $89
Current: $76.30
Upside: +16.64%
SI-BONE
Feb 24, 2026
Reiterates: Buy
Price Target: $23 → $24
Current: $15.70
Upside: +52.87%
iRhythm Holdings
Feb 23, 2026
Reiterates: Buy
Price Target: $215 → $200
Current: $128.46
Upside: +55.69%
Tandem Diabetes Care
Feb 23, 2026
Reiterates: Hold
Price Target: $24 → $27
Current: $25.23
Upside: +7.02%
Integer Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $86.34
Upside: +12.35%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $390 → $360
Current: $245.45
Upside: +46.67%
DexCom
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $73.78
Upside: +8.43%
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $96 → $70
Current: $64.81
Upside: +8.01%
Feb 11, 2026
Maintains: Hold
Price Target: $92 → $89
Current: $87.18
Upside: +2.09%
Feb 5, 2026
Maintains: Buy
Price Target: $120 → $95
Current: $76.22
Upside: +24.64%
Feb 2, 2026
Maintains: Buy
Price Target: $37 → $25
Current: $12.52
Upside: +99.68%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $342.30
Upside: +9.26%
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $35.36
Upside: +27.26%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $1.66
Upside: +80.72%
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $387.02
Upside: +1.29%
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $98.10
Upside: +9.07%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $496.25
Upside: +30.98%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $121.12
Upside: +19.72%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $93.80
Upside: +11.94%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $13.37
Upside: +49.59%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $10.43
Upside: +43.82%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $122.93
Upside: +11.45%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $99.49
Upside: +13.58%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $7.61
Upside: +162.81%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $84.68
Upside: -3.16%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $176.54
Upside: +41.61%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.00
Upside: +766.67%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $189.02
Upside: +307.36%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $75.45
Upside: +12.66%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $11.99
Upside: +66.81%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $30.65
Upside: -11.91%